The domains are scored from 0 (=no impairment) to 6 (=severe impairment) as perceived by the subject during the previous

week. The RQLQ has strong evaluative and discriminatory properties (Juniper et al. 2002). Statistical analysis For all statistical analyses, SPSS version 15.0 and PASW 18.0 (SPSS Inc., Chicago, IL, USA) were used. The eight health indices in SF-36 were calculated according to a SAS program provided by the HRQL group at the Sahlgrenska University hospital in Gothenburg (www.​hrql.​se), who handles the Swedish version of SF-36. We calculated mean, standard deviation check details (SD) and 95 % confidence interval as parameters for the QoL data, as the SAS program delivers mean values and SD. Visually assessed p–p-plots suggested that the data were normally distributed. For comparisons between groups, the Mann–Whitney U test was employed, and for changes within the groups, the Wilcoxon signed-ranks

test. This is also valid for the analysis of biomarkers and symptoms. The significance level was set at 5 %. Variables with dichotomous outcomes were Y 27632 analyzed with a generalized model with a logit link (i.e., logistic regression). Continuous variables were analyzed with a linear mixed model with restricted maximum likelihood (REML) estimation and a diagonal covariance matrix. In both models, repeated measures were identified by personal selleck kinase inhibitor identification number and day in study. For the continuous variables stiripentol “High-lifting blond,” “Hair Dye,” “Blond Hair Dye” and “Brown Hair Dye,” the final Hessian matrix was not positive. These were therefore dichotomized into the categories 0 and ≥1 and analyzed with the logit link. Results Diary Symptoms and medication used The S+ group had increased nasal symptoms steadily during the exposure period. The PA group had more nasal symptoms (running, itching nose, sneezes) from the start than the S+ group, and the symptoms varied from week to week (Table 2). The eye symptoms varied less than the nasal symptoms. The OR for eye symptoms in the PA group compared

to the S+ group was 8.07 (CI 95 % −3.20, −0.98; P < 0.001). In relation to the working days, the number of symptoms in the S+ group decreased during weekends and had a clear increase during the work days, especially at the end of the study period contrary to the PA group whose symptoms increased during days off work (Fig. 2). When the different nasal symptoms were studied separately, the S+ group had less sneezing and a tendency to more blockage than the PA group (Table 3). Nasal decongestants were consumed in the S+ group only during two percent of the study days. The PA group took antihistamines during 30 % of the study days. Furthermore, 8.2 % of the days they took antihistamines in combination with other allergy medications (data not shown).